Skip to main content

Table 1 Baseline characteristics of participants categorized by SHR

From: Risk analysis and mediation analysis of stress hyperglycemia ratio and all-cause mortality in patients with acute kidney injury

Variables

Overall

n = 3703

T1 (≤ 0.95)

n = 1236

T2 (0.95–1.25)

n = 1233

T3 (> 1.25)

n = 1234

P-value

Age (years)

68.4 (56.8, 79.1)

69.6 (57.9, 79.9)

68.9 (56.8, 79.8)

67.1 (56.0, 77.5)

0.003

Male, n (%)

2163 (58.4)

715 (57.9)

733 (59.5)

715 (57.9)

0.664

BMI (kg/m2)

28.6 (24.5, 33.8)

28.7 (24.3, 33.5)

28.2 (24.5, 33.5)

29.1 (24.7, 34.3)

0.025

SOFA

4.0 (2.0, 6.0)

3.0 (1.0, 5.0)

3.0 (2.0, 5.0)

5.0 (2.0, 8.0)

<0.001

SAPS II

33.0 (26.0, 42.0)

32.0 (25.0, 40.0)

33.0 (26.0, 40.0)

36.0 (28.0, 45.0)

<0.001

Comorbidities, n (%)

     

 CKD

756 (20.4)

255 (20.6)

211 (17.1)

290 (23.5)

<0.001

 HF

1179 (31.8)

365 (29.5)

364 (29.5)

450 (36.5)

<0.001

 RF

1075 (29.0)

269 (21.8)

322 (26.1)

484 (39.2)

<0.001

 Hypertension

1833 (49.5)

618 (50.0)

643 (52.2)

572 (46.4)

0.014

 Diabetes

898 (24.3)

298 (24.1)

247 (20.0)

353 (28.6)

<0.001

 COPD

238 (6.4)

73 (5.9)

74 (6.0)

91 (7.4)

0.250

 Malignancy

562 (15.2)

174 (14.1)

216 (17.5)

172 (13.9)

0.019

 ACS

405 (10.9)

97 (7.9)

127 (10.3)

181 (14.7)

<0.001

Interventions, n (%)

     

 RRT

258 (7.0)

63 (5.1)

70 (5.7)

125 (7.0)

<0.001

 Diuretics

1195 (32.3)

371 (30.0)

364 (29.5)

460 (37.3)

<0.001

 Vasoactive drugs

738 (19.9)

180 (14.6)

192 (15.6)

366 (29.7)

<0.001

Laboratory tests

     

 WBC (K/uL)

10.7 (8.0, 14.3)

9.2 (7.1, 11.9)

10.8 (9.2, 13.7)

12.6 (9.2, 16.8)

<0.001

 Hemoglobin (g/dL)

11.9 (10.2, 13.4)

11.8 (10.3, 13.4)

12.1 (10.5, 13.5)

11.6 (9.9, 13.4)

<0.001

 RDW (%)

14.0 (13.2, 15.1)

14.0 (13.2, 15.1)

13.8 (13.1, 14.9)

14.1 (13.2, 15.3)

<0.001

 Platelet (K/uL)

204.0 (159.0, 259.0)

208.0 (162.0, 259.0)

206.0 (163.0, 256.0)

200.5 (152.0, 262.0)

0.124

 Creatinine (mg/dL)

1.0 (0.8, 1.4)

1.0 (0.7, 1.4)

1.0 (0.8, 1.3)

1.1 (0.8, 1.6)

<0.001

 Albumin (g/dL)

3.3 (2.9, 3.7)

3.4 (2.9, 3.8)

3.4 (2.9, 3.8)

3.3 (2.8, 3.7)

<0.001

 BUN (mg/dL)

19.0 (14.0, 29.0)

18.0 (13.0, 28.0)

18.0 (13.0, 26.0)

21.0 (15.0, 34.0)

<0.001

 TC (mg/dL)

156.0 (124.1, 193.0)

155.0 (125.0, 191.0)

158.0 (125.0, 195.0)

156.0 (121.6, 192.2)

0.118

 TG (mg/dL)

119.0 (87.0, 202.6)

119.0 (87.0, 191.6)

119.0 (85.0, 197.0)

127.0 (91.3, 219.5)

0.014

 ALT (U/L)

25.0 (17.0, 38.0)

25.0 (16.0, 31.0)

25.0 (18.0, 36.0)

25.0 (20.0, 53.0)

<0.001

 AST (U/L)

33.0 (23.0, 53.0)

33.0 (21.0, 42.0)

33.0 (24.0, 47.0)

33.0 (27.0, 80.0)

<0.001

 Sodium (mmol/L)

138.0 (137.0, 140.0)

138.0 (138.0, 141.0)

138.0 (137.0, 140.0)

138.0 (136.0, 140.0)

<0.001

 Potassium (mmol/L)

4.1 (3.7, 4.5)

4.0 (3.7, 4.4)

4.0 (3.7, 4.4)

4.2 (3.7, 4.6)

<0.001

 Chlorine (mmol/L)

103.0 (100.0, 107.0)

104.0 (101.0, 107.0)

103.0 (100.0, 106.0)

102.0 (98.0, 106.0)

<0.001

 Glucose (mg/dL)

137.0 (109.0, 191.0)

104.0 (92.0, 126.0)

131.0 (116.0, 153.0)

204.0 (164.0, 277.0)

<0.001

 HbA1c (%)

5.9 (5.5, 6.8)

6.0 (5.6, 7.2)

5.8 (5.4, 6.4)

6.0 (5.4, 6.9)

<0.001

  1. SHR: stress hyperglycemia ratio; BMI, body mass index; SOFA, sequential organ failure assessment; SAPS II, simplified acute physiology score II; CKD, chronic kidney disease; HF, heart failure; RF, respiratory failure; COPD, chronic obstructive pulmonary diseases; ACS, acute coronary syndrome; RRT, renal replacement therapy; WBC, white blood cell; RDW, red blood cell distribution width; BUN, blood urea nitrogen; TC, total cholesterol; TG, triglyceride; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HbA1c: glycosylated hemoglobin A1c.